Search results
Results from the WOW.Com Content Network
Neuroangiogenesis is implicated in a number of pathologies, including endometriosis, [4] brain tumors, [5] and senile dementias, such as Alzheimer's disease. [6] Each of these incurs a significant cost for the healthcare industry, meaning that complete understanding of processes involved – including neuroangiogenesis – is necessary to ...
Angiogenesis is the physiological process through which new blood vessels form from pre-existing vessels, [1] [2] [3] formed in the earlier stage of vasculogenesis.
Comparison of healthy vs. dysfunctional vascular endothelium. In vascular diseases, endothelial dysfunction is a systemic pathological state of the endothelium.The main cause of endothelial dysfunction is impaired bioavailability of nitric oxide.
Drug delivery to the brain is the process of passing therapeutically active molecules across the blood–brain barrier into the brain.This is a complex process that must take into account the complex anatomy of the brain as well as the restrictions imposed by the special junctions of the blood–brain barrier.
The development of the nervous system in humans, or neural development, or neurodevelopment involves the studies of embryology, developmental biology, and neuroscience.These describe the cellular and molecular mechanisms by which the complex nervous system forms in humans, develops during prenatal development, and continues to develop postnatally.
Angiogenesis is the natural healing process by which new blood vessels are formed to supply the organ or part in deficit with oxygen-rich blood. The goal of therapeutic angiogenesis is to stimulate the creation of new blood vessels in ischemic organs, tissues, or parts with the hope of increasing the level of oxygen-rich blood reaching these areas.
Dr. Ralph Sacco, left, reviews a patient’s case with vascular neurology trainee Dr. Hartej Sethi, right, at the University of Miami. Dr. Sacco was the first neurologist to head the American ...
The mesolimbic pathway and its positioning in relation to the other dopaminergic pathways. The mesolimbic pathway is a collection of dopaminergic (i.e., dopamine-releasing) neurons that project from the ventral tegmental area (VTA) to the ventral striatum, which includes the nucleus accumbens (NAcc) and olfactory tubercle. [9]